{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:55:32Z","timestamp":1789055732609,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Anestesiolog\u00eda y Reanimaci\u00f3n (English Edition)"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.redare.2022.11.004","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T10:34:14Z","timestamp":1693996454000},"page":"34-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["COVID-19 thromboprophylaxis. New evidence"],"prefix":"10.1016","volume":"71","author":[{"given":"R.","family":"Ferrandis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gomez-Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redare.2022.11.004_bib0005","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/rth2.12439","article-title":"Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis","volume":"4","author":"Nopp","year":"2020","journal-title":"Res Pract Thromb Haemost."},{"key":"10.1016\/j.redare.2022.11.004_bib0010","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1473-3099(20)30434-5","article-title":"Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study","volume":"20","author":"Carsana","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.redare.2022.11.004_bib0015","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis","volume":"18","author":"Panigada","year":"2020","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.redare.2022.11.004_bib0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.redar.2020.05.007","article-title":"SEDAR-SEMICYUC consensus on the management of haemostasis disorders in severe COVID-19 patients","volume":"67","author":"Llau","year":"2020","journal-title":"Rev Esp Anestesiol Reanim."},{"key":"10.1016\/j.redare.2022.11.004_bib0025","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jacc.2021.12.023","article-title":"Anticoagulation in patients with COVID-19: JACC review topic of the week","volume":"79","author":"Farkouh","year":"2022","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.redare.2022.11.004_bib0030","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211008999","article-title":"Anticoagulation and in-hospital mortality from coronavirus disease 2019: a systematic review and meta-analysis","volume":"27","author":"Moonla","year":"2021","journal-title":"Clin Appl Thromb Hemost."},{"issue":"3","key":"10.1016\/j.redare.2022.11.004_bib0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.redar.2022.01.014","article-title":"Eficacia de la tromboprofilaxis con heparina de bajo peso molecular en pacientes cr\u00edticos con COVID-19: estudio observacional, propectivo y multic\u00e9ntrico","volume":"70","author":"Ferrandis","year":"2022","journal-title":"Rev Esp Anestesiol Reanim"},{"key":"10.1016\/j.redare.2022.11.004_bib0040","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.3390\/jcm10235549","article-title":"High versus standard intensity of thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis","volume":"10","author":"Kollias","year":"2021","journal-title":"J Clin Med."},{"key":"10.1016\/j.redare.2022.11.004_bib0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jcm11010057","article-title":"Safety and efficacy of intermediate- and therapeutic-dose anticoagulation for hospitalised patients with COVID-19: a systematic review and meta-analysis","volume":"11","author":"Reis","year":"2021","journal-title":"J Clin Med."},{"key":"10.1016\/j.redare.2022.11.004_bib0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/acem.14417","article-title":"Higher-dose versus standard-dose prophylactic anticoagulation in hospitalized patients with COVID-19","volume":"29","author":"Long","year":"2022","journal-title":"Acad Emerg Med."},{"key":"10.1016\/j.redare.2022.11.004_bib0055","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/cpt.2504","article-title":"Anticoagulant treatment regimens in patients with COVID-19: a meta-analysis","volume":"111","author":"Jorda","year":"2022","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.redare.2022.11.004_bib0060","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-022-01809-8","article-title":"Efficacy of different anticoagulant doses for patients with COVID-19: a systematic review and network meta-analysis","author":"Yasuda","year":"2022","journal-title":"Infection"},{"key":"10.1016\/j.redare.2022.11.004_bib0065","article-title":"Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with COVID-19: a systematic review and meta-analysis","author":"Wills","year":"2022","journal-title":"medRxiv. [Preprint]."},{"key":"10.1016\/j.redare.2022.11.004_bib0070","article-title":"Anticoagulants for people hospitalized with COVID-19","volume":"10","author":"Flumignan","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.redare.2022.11.004_bib0075","doi-asserted-by":"crossref","first-page":"e524","DOI":"10.1016\/S2352-3026(21)00105-8","article-title":"COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year","volume":"8","author":"Leentjens","year":"2021","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.redare.2022.11.004_bib0080","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with Covid-19","volume":"385","author":"Goligher","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.redare.2022.11.004_bib0085","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19","volume":"385","author":"Lawler","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.redare.2022.11.004_bib0090","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jamainternmed.2021.6203","article-title":"Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial","volume":"181","author":"Spyropoulos","year":"2021","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.redare.2022.11.004_bib0095","doi-asserted-by":"crossref","first-page":"n2400","DOI":"10.1136\/bmj.n2400","article-title":"Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial","volume":"375","author":"Sholzberg","year":"2021","journal-title":"BMJ."},{"key":"10.1016\/j.redare.2022.11.004_bib0100","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/jama.2021.4152","volume":"325","author":"Sadeghipour","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.redare.2022.11.004_bib0105","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/jth.15450","article-title":"Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: a multi-center, open-label, randomized controlled trial","volume":"19","author":"Perepu","year":"2021","journal-title":"J Thromb Haemost."},{"issue":"8","key":"10.1016\/j.redare.2022.11.004_bib0110","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(22)00175-2","article-title":"Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial","volume":"9","author":"Barco","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.redare.2022.11.004_bib0115","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial","volume":"397","author":"Lopes","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.redare.2022.11.004_bib0120","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1055\/a-1414-5216","article-title":"Sulodexide in the treatment of patients with early stages of COVID-19: a randomized controlled trial","volume":"121","author":"Gonzalez-Ochoa","year":"2021","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.redare.2022.11.004_bib0125","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/jama.2021.17272","article-title":"Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: the ACTIV-4B randomized clinical trial","volume":"326","author":"Connors","year":"2021","journal-title":"JAMA."},{"key":"10.1016\/j.redare.2022.11.004_bib0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ahj.2021.08.016","article-title":"Medically ill hospitalized patients for COVID-19 thrombosis extended prophylaxis with rivaroxaban therapy: rationale and design of the MICHELLE trial","volume":"242","author":"Ramacciotti","year":"2021","journal-title":"Am Heart J."},{"key":"10.1016\/j.redare.2022.11.004_bib0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(21)01825-0","article-title":"Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"399","year":"2022","journal-title":"Lancet."},{"key":"10.1016\/j.redare.2022.11.004_bib0140","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.2022.2910","article-title":"Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: a randomized clinical trial","volume":"327","author":"Bradbury","year":"2022","journal-title":"J Am Med Assoc."},{"key":"10.1016\/j.redare.2022.11.004_bib0145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jama.2021.23605","article-title":"Effect of P2Y12 inhibitors on survival free of organ support among non-critically ill hospitalized patients with COVID-19: a randomized clinical trial","volume":"327","author":"Berger","year":"2022","journal-title":"JAMA."},{"key":"10.1016\/j.redare.2022.11.004_bib0150","article-title":"The effects of aspirin on the outcome of COVID-19: a systematic review and meta-analysis","volume":"12","author":"Wijaya","year":"2021","journal-title":"Clin Epidemiol Glob Health."},{"key":"10.1016\/j.redare.2022.11.004_bib0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijid.2021.05.016","article-title":"Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: a systematic review and meta-analysis of adjusted effect estimates","volume":"108","author":"Martha","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.redare.2022.11.004_bib0160","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/heartjnl-2021-319552","article-title":"Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry","volume":"108","author":"Santoro","year":"2022","journal-title":"Heart."},{"key":"10.1016\/j.redare.2022.11.004_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2021.06.014","article-title":"Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes","volume":"205","author":"Rivera-Caravaca","year":"2021","journal-title":"Thromb Res."},{"key":"10.1016\/j.redare.2022.11.004_bib0170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2021.12.010","article-title":"The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: a population-based cohort study","volume":"211","author":"Abdel-Qadir","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.redare.2022.11.004_bib0175","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s11239-021-02486-4","article-title":"Prior use of anticoagulation is associated with a better survival in COVID-19","volume":"52","author":"Buenen","year":"2021","journal-title":"J Thromb Thrombolysis."},{"key":"10.1016\/j.redare.2022.11.004_bib0180","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.633878","article-title":"Preexisting oral anticoagulant therapy ameliorates prognosis in hospitalized COVID-19 patients","volume":"8","author":"Iaccarino","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.redare.2022.11.004_bib0185","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.amjcard.2022.02.007","article-title":"Effect on morbidity and mortality of direct oral anticoagulants in patients with COVID-19","volume":"171","author":"Toubasi","year":"2022","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.redare.2022.11.004_bib0190","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ajem.2022.01.059","article-title":"The effect of previous oral anticoagulant use on clinical outcomes in COVID-19: a systematic review and meta-analysis","volume":"54","author":"Zeng","year":"2022","journal-title":"Am J Emerg Med."},{"key":"10.1016\/j.redare.2022.11.004_bib0195","unstructured":"World Health Organization. COVID-19 clinical management: living guidance. 25 January 2021. [Consultado 5 abril 2022]. Available from: https:\/\/www.who.int\/es\/publications\/i\/item\/WHO-2019-nCoV-clinical-2021-1."},{"key":"10.1016\/j.redare.2022.11.004_bib0200","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00048-2021","article-title":"Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline","volume":"57","author":"Chalmers","year":"2021","journal-title":"Eur Respir J."},{"key":"10.1016\/j.redare.2022.11.004_bib0205","volume":"40","author":"Godon","year":"2021","journal-title":"Anaesth Crit Care Pain Med."},{"key":"10.1016\/j.redare.2022.11.004_bib0210","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/bloodadvances.2021005493","article-title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients","volume":"5","author":"Cuker","year":"2021","journal-title":"Blood Adv"},{"issue":"Suplemento COVID","key":"10.1016\/j.redare.2022.11.004_bib0215","first-page":"047","volume":"91","author":"Guillermo-Esposito","year":"2021","journal-title":"Arch Cardiol Mex"},{"key":"10.1016\/j.redare.2022.11.004_bib0220","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/eurheartj\/ehab866","volume":"43","author":"Task Force for the management of COVID-19 of the European Society of Cardiology","year":"2022","journal-title":"Eur Heart J."},{"key":"10.1016\/j.redare.2022.11.004_bib0225","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s40121-021-00487-7","article-title":"Clinical management of adult patients with COVID-19 outside intensive care units: guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)","volume":"10","author":"Bassetti","year":"2021","journal-title":"Infect Dis Ther."},{"key":"10.1016\/j.redare.2022.11.004_bib0230","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/bloodadvances.2021005945","article-title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis","volume":"6","author":"Cuker","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.redare.2022.11.004_bib0235","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jiph.2021.10.005","article-title":"The Saudi Critical Care Society practice guidelines on the management of COVID-19 in the ICU: therapy section","volume":"15","author":"Alhazzani","year":"2022","journal-title":"J Infect Public Health."},{"key":"10.1016\/j.redare.2022.11.004_bib0240","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s15010-021-01645-2","article-title":"Key summary of German national treatment guidance for hospitalized COVID-19 patients: Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated17.05.2021)","volume":"50","author":"Malin","year":"2022","journal-title":"Infection."},{"issue":"22","key":"10.1016\/j.redare.2022.11.004_bib0245","first-page":"00250","article-title":"Thromboprophylaxis in patients with COVID-19: a brief update to the CHEST guideline and expert panel report [publicado \u201con line\u201d antes de su publicaci\u00f3n impresa, 12 de febrero de 2022]","volume":"S0012-3692","author":"Moores","year":"2022","journal-title":"Chest."},{"key":"10.1016\/j.redare.2022.11.004_bib0250","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1111\/jth.15809","article-title":"Good practice statements for antithrombotic therapy in the management of COVID-19: guidance from the SSC of the ISTH","volume":"20","author":"Spyropoulos","year":"2022","journal-title":"J Thromb Haemost."}],"container-title":["Revista Espa\u00f1ola de Anestesiolog\u00eda y Reanimaci\u00f3n (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341192923001361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341192923001361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:40:47Z","timestamp":1762422047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2341192923001361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2341192923001361"],"URL":"https:\/\/doi.org\/10.1016\/j.redare.2022.11.004","relation":{},"ISSN":["2341-1929"],"issn-type":[{"value":"2341-1929","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 thromboprophylaxis. New evidence","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Anestesiolog\u00eda y Reanimaci\u00f3n (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redare.2022.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Anestesiolog\u00eda, Reanimaci\u00f3n y Terap\u00e9utica del Dolor.","name":"copyright","label":"Copyright"}]}}